March 30, 2023 10:26 AM EDT

Diffusion to hand Nasdaq spot to EIP Pharma for PhIIb dementia study of ex-Vertex drug

Kyle LaHucik

Senior Reporter

One of the more than a dozen bidders for Diffusion Pharmaceuticals’ spot on Nasdaq has prevailed.

Boston biotech EIP Pharma will

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

Corvus' early-phase atopic dermatitis data prompt stock rally

Revolution’s KRAS drugs appear competitive in several lung cancer settings

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges